← Back to guidelines
Cardiology20 papers

Congenital pulmonary lymphatic dysplasia syndrome

Last edited: 4/22/2026

Overview

Congenital pulmonary lymphatic dysplasia syndrome involves abnormalities in the development of lymphatic vessels within the lungs, leading to conditions such as pleural effusions, lung hypoplasia, and chronic lymphangiectasis. These defects can result from genetic mutations affecting key transcription factors like SOX18. 12

Diagnosis

  • Key Diagnostic Criteria:
  • - Presence of pleural effusions in utero or neonatal period. - Morphometric evidence of interlobular septal lymphatic hypoplasia. - Lung hypoplasia or normal lung weight with associated congenital anomalies. 2
  • Recommended Tests:
  • - Postmortem lung examination for morphometric analysis. - Histopathological evaluation for lymphangiectasia and connective tissue changes. 23

    Management

  • First-Line Treatments:
  • - Supportive care for respiratory insufficiency. - Management of associated congenital anomalies (e.g., vascular ring). 2
  • Adjunctive Treatments:
  • - No specific pharmacological treatments mentioned; focus on symptomatic management. 123

    Special Populations

  • Pediatrics:
  • - Early recognition crucial due to potential fatal outcomes in neonates. 2
  • Comorbidities:
  • - Association with Turner's syndrome and persistent lymphoedema beyond infancy is rare but documented. 3

    Key Recommendations

  • Conduct postmortem morphometric analysis of lung tissue to identify interlobular septal lymphatic hypoplasia in cases of unexplained fetal pleural effusions. (Evidence: Moderate) 2
  • Histopathological examination should be considered in patients with persistent lymphoedema beyond infancy, especially in those with Turner's syndrome, to rule out congenital lymphangiectasis. (Evidence: Weak) 3
  • Focus on supportive care and management of associated congenital anomalies in neonates with suspected congenital pulmonary lymphatic dysplasia syndrome. (Evidence: Expert opinion) 2
  • References

    1 François M, Caprini A, Hosking B, Orsenigo F, Wilhelm D, Browne C et al.. Sox18 induces development of the lymphatic vasculature in mice. Nature 2008. link 2 Thibeault DW, Zalles C, Wickstrom E. Familial pulmonary lymphatic hypoplasia associated with fetal pleural effusions. The Journal of pediatrics 1995. link70043-9) 3 Perry HD, Cossari AJ. Chronic lymphangiectasis in Turner's syndrome. The British journal of ophthalmology 1986. link

    Original source

    1. [1]
      Sox18 induces development of the lymphatic vasculature in mice.François M, Caprini A, Hosking B, Orsenigo F, Wilhelm D, Browne C et al. Nature (2008)
    2. [2]
      Familial pulmonary lymphatic hypoplasia associated with fetal pleural effusions.Thibeault DW, Zalles C, Wickstrom E The Journal of pediatrics (1995)
    3. [3]
      Chronic lymphangiectasis in Turner's syndrome.Perry HD, Cossari AJ The British journal of ophthalmology (1986)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG